Analysis of signal transduction in B chronic lymphocytic leukemia cells.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Blood

• Publication date

  1988-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V71.5.1461.1461PMID 3129049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hairy cell leukaemia: effects of phorbol ester on cell morphology and adherence and comparison with other B-cell neoplasias.

  2009cited by this paper
• Activation of malignant B-lymphocytes: pathophysiologic and clinical importance.

  2009cited by this paper
• Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cells.

  1987cited by this paper
• CD5-positive B cells after T cell depleted bone marrow transplantation.

  1987cited by this paper
• Normal cellular counterparts of B cell chronic lymphocytic leukemia.

  1987cited by this paper
• Activation of B chronic lymphocytic leukaemia cells by Branhamella catarrhalis.

  1987cited by this paper
• Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal.

  1987cited by this paper
• T-24.B-cell differentiation factor induces immunoglobulin secretion in human B cells without prior cell replication.

  1987cited by this paper
• Phenotypic modulation of chronic lymphocytic, prolymphocytic, and lymphoplasmacytic leukemia cells by TPA: induction of TRAP isoenzyme 5 and HD6 (CD22) antigen and enhancement of IgM messenger RNA.

  1987cited by this paper
• Tumor‐promoting phorbol esters suppress receptor‐stimulated inositol phospholipid degradation and Ca2+ mobilization in mouse lymphocytes

  1987cited by this paper
• Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes

  1987cited by this paper
• Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical.

  1987cited by this paper
• Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2

  1987cited by this paper
• Identity of common phosphoprotein substrates stimulated by interleukin 2 and diacylglycerol suggests a role of protein kinase C for IL 2 signal transduction

  1987cited by this paper
• Induction of Proliferation and Differentiation of Leukaemic B Cells from Patients with Chronic Lymphocytic Leukaemia by Anti‐μ and Conditioned Medium

  1987cited by this paper
• The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors.

  1987cited by this paper
• The human bladder carcinoma line T-24 secretes a human B-cell differentiation factor.

  1987cited by this paper
• Interferon β2 as a promoter of growth and differentiation of B cells.

  1987cited by this paper
• Protein kinase C activation by diacylglycerol second messengers.

  1986cited by this paper
• Phorbol diesters inhibit enzymatic hydrolysis of diacylglycerols in vitro.

  1986cited by this paper
• Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia.

  1986cited by this paper
• Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production

  1986cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Protein kinase C activation by diacylglycerol second messengers

  1986cited by this paper
• Activation and proliferation signals in mouse B cells VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate

  1986cited by this paper
• Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro.

  1986cited by this paper
• Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.

  1986cited by this paper
• Immunoglobulin synthesis and secretion by leukemic B cells from patients with chronic lymphocytic leukemia.

  1986cited by this paper
• B cell growth and differentiation induced by supernatants of transformed epithelial cell lines

  1986cited by this paper
• Signal transduction and intracellular events in T-lymphocyte activation.

  1986cited by this paper
• Calcium ionophore A23187 primes human B-cells for activation by phorbol dibutyrate by converting receptors for phorbol dibutyrate from a low to high affinity state.

  1986cited by this paper
• Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2

  1986cited by this paper
• Protein kinase C in T-cell regulation.

  1986cited by this paper
• The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia

  1986cited by this paper
• Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.

  1986cited by this paper
• Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.

  1986cited by this paper
• The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin.

  1985cited by this paper
• Role of intracellular calcium mobilization in the regulation of protein kinase C-mediated membrane processes

  1985cited by this paper
• A Combination of Calcium Ionophore and 12‐O‐Tetradecanoyl‐Phorbol‐13‐Acetate (TPA) Stimulates the Growth of Purified Resting B Cells

  1985cited by this paper
• Interleukin 2-induced proliferation of leukemic human B cells

  1985cited by this paper
• In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.

  1985cited by this paper
• Synergy between B cell differentiation factors and interleukin 2, using a monoclonal system.

  1985cited by this paper
• Transmembrane signalling by the T3-antigen receptor complex.

  1985cited by this paper
• A model for intracellular translocation of protein kinase C involving synergism between Ca2+ and phorbol esters

  1985cited by this paper
• B lymphocyte receptors and polyphosphoinositide degradation.

  1985cited by this paper
• Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester

  1985cited by this paper
• Inositol trisphosphate, a novel second messenger in cellular signal transduction

  1984cited by this paper
• Production of antibody by human B cells under serum-free conditions.

  1984cited by this paper
• G proteins and dual control of adenylate cyclase.

  1984cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

  1984cited by this paper
• Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.

  1984cited by this paper
• The role of protein kinase C in cell surface signal transduction and tumour promotion

  1984cited by this paper
• Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures.

  1983cited by this paper
• Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings.

  1983cited by this paper
• Heterogeneity of the response of chronic lymphocytic leukemia cells to phorbol ester.

  1982cited by this paper
• A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

  1981cited by this paper
• Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.

  1981cited by this paper
• Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells

  1980cited by this paper
• Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas.

  1977cited by this paper

• and calcium ionophore lymphocytic leukemia cells during differentiation induced by phorbol ester Rapid expression of protooncogenes c-fos and c-myc in B-chronic

  2013cites this paper
• antibodies and propensity to apoptosis lymphocytic leukemias with different responses to anti-IgM CD38 expression distinguishes two groups of B-cell chronic

  2011cites this paper
• Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition

  2005cites this paper
• Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia.

  2000cites this paper
• S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

  1999cites this paper
• The cellular biology of B-cell chronic lymphocytic leukemia.

  1998cites this paper
• The granulocyte colony-stimulating factor (G-CSF)/G-CSF receptor (G-CSFR) system in B-cell chronic lymphocytic leukemia.

  1997cites this paper
• CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.

  1996cites this paper
• Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.

  1996cites this paper
• Defects in signal transduction pathways in chronic B lymphocytic leukemia cells.

  1995cites this paper
• Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.

  1995cites this paper
• In Vitro Regulation of Growth, Differentiation and Survival of Leukemic CD5+ B Cells

  1995cites this paper
• Regulation of transcription factors NF kappa B and AP-1 following tumour necrosis factor-alpha treatment of cells from chronic B cell leukaemia patients.

  1994cites this paper
• Regulation of transcription factors NFκB and AP‐1 following tumour necrosis factor‐α treatment of cells from chronic B cell leukaemia patients

  1994cites this paper
• Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.

  1993cites this paper
• Autocrine and paracrine growth loops in chronic lymphocytic leukemia.

  1993cites this paper
• B-cell chronic lymphocytic leukaemia populations respond stochastically to combinations of growth signals in vitro.

  1993cites this paper
• Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.

  1992cites this paper
• Mechanisms in B-Cell Neoplasia 1992

  1992cites this paper
• Interleukin‐2‐induced increase of a monoclonal b‐cell lymphocytosis. A novel In vivo interleukin‐2 effect?

  1992cites this paper
• On the role of endogenously produced TNF-alpha and IL-6 as regulators of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro.

  1992cites this paper
• Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte‐macrophage progenitors to recombinant GM‐CSF

  1991cites this paper
• Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.

  1991cites this paper
• Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

  1990cites this paper
• In vitro beta 2-microglobulin (beta 2m) secretion by normal and leukaemic B-cells: effects of recombinant cytokines and evidence for a differential response to the combined stimulus of phorbol ester and calcium ionophore.

  1990cites this paper
• 12-0-Tetradecanoyl Phorbol-13-Acetate (TPA) and Its Effect on Leukaemic Cells, In-vitro-A Review.

  1990cites this paper
• Differential responses of B-CLL clones to in vitro stimulation with cytokines.

  1990cites this paper
• Differential expression of TRAP Isoenzyme in B-CLL Cells Treated with Different Inducers.

  1990cites this paper
• Down‐regulation of CD5 mRNA in B‐chronic lymphocytic leukemia cells by differentiation‐inducing agents

  1990cites this paper
• Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B‐type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signals

  1989cites this paper
• Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.

  1989cites this paper
• Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.

  1989cites this paper
• Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.

  1989cites this paper
• Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.

  1989cites this paper
• Which cells do respond during in vitro stimulation of B-CLL and HCL cultures?

  1988cites this paper